Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trialMark T. Drayson, Janet Dunn, Stella Bowcock et al.|The Lancet Oncology|2019Cited by 160
Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive updateMohammad Shahid, Peter M. Hawkey, Haris M. Khan et al.|Critical Reviews in Microbiology|2009Cited by 131